{"id":"lorazepam-and-fmri","safety":{"commonSideEffects":[{"rate":"30-50","effect":"Sedation"},{"rate":"15-30","effect":"Dizziness"},{"rate":"10-20","effect":"Ataxia"},{"rate":"variable with duration","effect":"Dependence/tolerance"},{"rate":"rare at therapeutic doses","effect":"Respiratory depression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lorazepam binds to GABA-A receptors and potentiates the inhibitory effects of GABA, leading to anxiolytic, sedative, and anticonvulsant effects. The fMRI component allows researchers to map and measure changes in brain activation patterns and functional connectivity induced by lorazepam administration, typically used in research settings to understand drug effects on neural circuits rather than as a therapeutic mechanism itself.","oneSentence":"Lorazepam is a benzodiazepine that enhances GABAergic inhibitory neurotransmission in the central nervous system, and fMRI is a neuroimaging technique used to visualize brain activity changes in response to the drug.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:53:02.771Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anxiety disorders"},{"name":"Insomnia"},{"name":"Seizure disorders"},{"name":"Alcohol withdrawal"}]},"trialDetails":[{"nctId":"NCT06004115","phase":"PHASE4","title":"Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression","status":"RECRUITING","sponsor":"Laureate Institute for Brain Research, Inc.","startDate":"2023-11-08","conditions":"Depression, Anxiety, Fear, Depression","enrollment":165},{"nctId":"NCT00696033","phase":"NA","title":"Exploring the Effects of Diazepam and Lorazepam","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2007-07","conditions":"Healthy Subjects","enrollment":22},{"nctId":"NCT04004416","phase":"PHASE4","title":"Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2020-01-16","conditions":"Schizophrenia, Bipolar Disorder, Healthy","enrollment":143},{"nctId":"NCT03829839","phase":"PHASE1","title":"Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity","status":"COMPLETED","sponsor":"University Hospital, Bonn","startDate":"2016-03-03","conditions":"Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs","enrollment":120},{"nctId":"NCT02407704","phase":"PHASE4","title":"A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise","status":"COMPLETED","sponsor":"Kirk Erickson, PhD","startDate":"2015-03","conditions":"Depression, Depressive Disorder, Major, Depressive Disorder","enrollment":31},{"nctId":"NCT01566539","phase":"NA","title":"Biological Basis of Individual Variation in Social Cooperation","status":"COMPLETED","sponsor":"Emory University","startDate":"2008-04","conditions":"Healthy","enrollment":707},{"nctId":"NCT00513565","phase":"PHASE1","title":"A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-09-13","conditions":"Depressive Disorder and Anxiety Disorders","enrollment":22},{"nctId":"NCT00424697","phase":"PHASE1","title":"A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-03","conditions":"Healthy Subjects","enrollment":26}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ativan"],"phase":"marketed","status":"active","brandName":"Lorazepam and fMRI","genericName":"Lorazepam and fMRI","companyName":"University of Michigan","companyId":"university-of-michigan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lorazepam is a benzodiazepine that enhances GABAergic inhibitory neurotransmission in the central nervous system, and fMRI is a neuroimaging technique used to visualize brain activity changes in response to the drug. Used for Anxiety disorders, Insomnia, Seizure disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}